$201.78
1.34% yesterday
NYSE, Apr 11, 10:00 pm CET
ISIN
US0758871091
Symbol
BDX

Becton, Dickinson & Stock price

$201.78
-23.14 10.29% 1M
-34.72 14.68% 6M
-25.09 11.06% YTD
-38.83 16.14% 1Y
-68.23 25.27% 3Y
-40.06 16.57% 5Y
+62.90 45.29% 10Y
NYSE, Closing price Fri, Apr 11 2025
+2.66 1.34%
ISIN
US0758871091
Symbol
BDX
Sector

Key metrics

Market capitalization $57.94b
Enterprise Value $75.87b
P/E (TTM) P/E ratio 33.52
EV/FCF (TTM) EV/FCF 25.84
EV/Sales (TTM) EV/Sales 3.68
P/S ratio (TTM) P/S ratio 2.81
P/B ratio (TTM) P/B ratio 2.30
Dividend yield 1.88%
Last dividend (FY24) $3.80
Revenue growth (TTM) Revenue growth 5.89%
Revenue (TTM) Revenue $20.64b
EBIT (operating result TTM) EBIT $2.92b
Free Cash Flow (TTM) Free Cash Flow $2.94b
Cash position $830.00m
EPS (TTM) EPS $6.02
P/E forward 23.03
P/S forward 2.65
EV/Sales forward 3.47
Short interest 1.00%
Show more

Is Becton, Dickinson & a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Becton, Dickinson & Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Becton, Dickinson & forecast:

15x Buy
79%
4x Hold
21%

Analyst Opinions

19 Analysts have issued a Becton, Dickinson & forecast:

Buy
79%
Hold
21%

Financial data from Becton, Dickinson &

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
20,640 20,640
6% 6%
100%
- Direct Costs 11,279 11,279
1% 1%
55%
9,361 9,361
16% 16%
45%
- Selling and Administrative Expenses 3,012 3,012
26% 26%
15%
- Research and Development Expense 1,243 1,243
2% 2%
6%
5,106 5,106
14% 14%
25%
- Depreciation and Amortization 2,190 2,190
2% 2%
11%
EBIT (Operating Income) EBIT 2,916 2,916
27% 27%
14%
Net Profit 1,748 1,748
39% 39%
8%

In millions USD.

Don't miss a Thing! We will send you all news about Becton, Dickinson & directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Becton, Dickinson & Stock News

Neutral
PRNewsWire
9 days ago
FRANKLIN LAKES, N.J. , April 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m.
Neutral
Reuters
11 days ago
Medical device maker Becton Dickinson has begun discussions to sell its life sciences division, valued at $21 billion, and is in talks with competitors such as Thermo Fisher Scientific and Danaher , the Financial Times reported on Tuesday.
Positive
Seeking Alpha
12 days ago
Dividend Aristocrats are outperforming the S&P 500 in 2025, demonstrating resilience, with NOBL up 1.78% YTD versus SPY's 4.9% decline. Top performers include Consolidated Edison (+22.98%), Brown & Brown (+20.65%), and AbbVie (+16.61%), showcasing strong double-digit gains. 29 out of 69 Dividend Aristocrats have announced dividend increases in 2025, with an average growth rate of 4.15%.
More Becton, Dickinson & News

Company Profile

Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through the following segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via Homecare business. The company was founded in 1897 and is headquartered in Franklin Lakes, NJ.

Head office United States
CEO Thomas Polen
Employees 74,000
Founded 1897
Website www.bd.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today